🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood
Start Date
2007-05
Trial ID
NCT00467740
Treatments Being Tested
The deleterious consequences of lung hyperinflation seem not to be restrict...
Status
Completed
Location
Kingston General Hospital
Start Date
2017-01-01
Trial ID
NCT03425617
Treatments Being Tested
This is a 4-week, multicenter, randomized, double-blind, parallel group and...
Status
Completed
Location
Ordination Dr. Robert Voves, 8330 Feldbach
Start Date
2016-03-08
Trial ID
NCT02683109
Treatments Being Tested
The decrease in physical activity due to increasing dyspnoea that over time...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 1
Start Date
2014-06
Trial ID
NCT02173769
Treatments Being Tested
The primary objective of this study is to assess the long-term efficacy and...
Status
Completed
Location
1222.14.5004 Boehringer Ingelheim Investigational Site
Start Date
2009-01
Trial ID
NCT00796653
Treatments Being Tested
The purpose of this study is to examine the effect of a combined LABA/LAMA ...
Status
Completed
Location
Fraunhofer ITEM
Start Date
2020-01-28
Trial ID
NCT04231214
Treatments Being Tested
This study looks at data from people with chronic obstructive pulmonary dis...
Status
Completed
Location
eMax health
Start Date
2021-12-17
Trial ID
NCT05169424
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00720499
Treatments Being Tested
To demonstrate the efficacy of inhaled tiotropium + olodaterol via Respimat...
Status
Completed
Location
SEC Lung
Start Date
2020-01-08
Trial ID
NCT04223843
Treatments Being Tested
Study to investigate safety and tolerability of single, inhaled doses (2.5 ...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02259946
Treatments Being Tested